LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Three Dimensional Paper Sensor Could Test for Disease

By LabMedica International staff writers
Posted on 15 Mar 2012
Image: Origami-inspired paper sensor can be easily assembled by hand. It may soon be able to inexpensively test for diseases like malaria and HIV (Photo courtesy of Alex Wang).
Image: Origami-inspired paper sensor can be easily assembled by hand. It may soon be able to inexpensively test for diseases like malaria and HIV (Photo courtesy of Alex Wang).
Origami-inspired paper sensor could test for malaria and Human Immunodeficiency Virus (HIV) for less than USD 0.10. Sensors can be printed out on an office printer, and take less than a minute to assemble.

These low-cost, "point-of-care" sensors could be useful in the developing world, where resources are often lacking to pay for lab-based tests, and where, even if the money is available, there infrastructure does not exist to transport biological samples to the lab.

Inspired by the paper-folding art of origami, chemists at The University of Texas at Austin (Texas; USA) have developed a 3-D paper sensor that may be able to test for diseases such as malaria and HIV.

One-dimensional paper sensors, such as those used in pregnancy tests, are already common but have limitations. The folded, 3-D sensors, developed by Richard Crooks, the Robert A. Welch professor of chemistry and doctoral student Hong Liu, can test for more substances in a smaller surface area and provide results for more complex tests.

"Anybody can fold them up," said Prof. Crooks. "You don't need a specialist, so you could easily imagine an [non-governmental organization] NGO with some volunteers folding these things up and passing them out. They're easy to produce as well, so the production could be shifted to the clientele as well. They don't need to be made in the developed world."

Prof. Crooks said that the principles underlying the sensor, which have been successfully tested on glucose and a common protein, are related to the home pregnancy test. A hydrophobic material, such as wax or photo resist, is laid down into tiny canyons on chromatography paper. It channels the sample to be tested—urine, blood, or saliva, for instance—to spots on the paper where test reagents have been embedded.

If the sample has whatever targets the sensor is designed to detect, it will react in an easily detectable manner. It might turn a specific color for example or fluoresce under a UV light. Then it can be read by eye.

Related Links:

The University of Texas at Austin


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Gel Cards
DG Gel Cards

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more